Real-time enrollment status for this relapsed myelodysplastic syndrome clinical trial
Current Status
Recruiting
Checked: July 14, 2026 at 1:24 AM UTC
| NCT Number | NCT06399640 |
| Recruiting Status | Recruiting |
| Condition | Relapsed Myelodysplastic Syndrome |
| Phase | Clinical Trial |
| Target Enrollment | 60 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Vanderbilt-Ingram Cancer Center |
| Last Updated on CT.gov | June 24, 2026 (2 weeks ago) |
As of July 14, 2026: Clinical trial NCT06399640 is currently recruiting participants. This clinical trial study for relapsed myelodysplastic syndrome is actively seeking new participants at 2 locations across the United States. The study is sponsored by Vanderbilt-Ingram Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06399640 is actively recruiting participants as of July 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06399640 was last updated 2 weeks ago (June 24, 2026). HelloStudys verifies this status automatically.